Portside Wealth Group LLC Increases Stake in U.S. Physical Therapy, Inc. $USPH

Portside Wealth Group LLC increased its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 78.6% in the second quarter, Holdings Channel.com reports. The firm owned 6,316 shares of the company’s stock after purchasing an additional 2,780 shares during the quarter. Portside Wealth Group LLC’s holdings in U.S. Physical Therapy were worth $494,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Integrated Quantitative Investments LLC bought a new stake in U.S. Physical Therapy in the second quarter worth about $1,114,000. Creative Planning lifted its stake in shares of U.S. Physical Therapy by 114.8% during the 2nd quarter. Creative Planning now owns 10,220 shares of the company’s stock worth $799,000 after acquiring an additional 5,462 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its holdings in U.S. Physical Therapy by 8.0% during the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 3,900 shares of the company’s stock valued at $305,000 after acquiring an additional 288 shares during the period. Police & Firemen s Retirement System of New Jersey grew its position in U.S. Physical Therapy by 5.7% in the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 3,247 shares of the company’s stock valued at $254,000 after acquiring an additional 176 shares during the last quarter. Finally, Geode Capital Management LLC increased its stake in U.S. Physical Therapy by 1.2% in the second quarter. Geode Capital Management LLC now owns 352,923 shares of the company’s stock worth $27,602,000 after purchasing an additional 4,306 shares during the period.

Wall Street Analysts Forecast Growth

USPH has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. assumed coverage on shares of U.S. Physical Therapy in a research note on Thursday, September 18th. They set an “overweight” rating and a $110.00 target price for the company. Wall Street Zen lowered shares of U.S. Physical Therapy from a “buy” rating to a “hold” rating in a report on Sunday, September 21st. Barrington Research restated an “outperform” rating and issued a $103.00 target price on shares of U.S. Physical Therapy in a research note on Friday, October 24th. Zacks Research raised shares of U.S. Physical Therapy to a “hold” rating in a research report on Friday, August 8th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of U.S. Physical Therapy in a research note on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, U.S. Physical Therapy currently has a consensus rating of “Moderate Buy” and a consensus price target of $110.25.

Insiders Place Their Bets

In other news, CFO Carey P. Hendrickson sold 698 shares of the stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $86.11, for a total value of $60,104.78. Following the transaction, the chief financial officer directly owned 27,808 shares of the company’s stock, valued at approximately $2,394,546.88. This represents a 2.45% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Nancy Ham sold 600 shares of the stock in a transaction that occurred on Thursday, September 11th. The stock was sold at an average price of $81.71, for a total transaction of $49,026.00. Following the completion of the transaction, the director owned 1,994 shares in the company, valued at approximately $162,929.74. This trade represents a 23.13% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 4,298 shares of company stock worth $361,441 over the last ninety days. Insiders own 2.00% of the company’s stock.

U.S. Physical Therapy Stock Down 1.4%

NYSE:USPH opened at $67.99 on Thursday. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.18 and a quick ratio of 1.18. U.S. Physical Therapy, Inc. has a 1-year low of $62.77 and a 1-year high of $101.19. The company has a 50-day moving average of $83.38 and a 200 day moving average of $80.09. The firm has a market cap of $1.03 billion, a PE ratio of 29.69, a price-to-earnings-growth ratio of 4.41 and a beta of 1.47.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings data on Tuesday, August 22nd. The company reported $0.90 EPS for the quarter. The company had revenue of $140.66 million during the quarter. U.S. Physical Therapy had a net margin of 5.05% and a return on equity of 8.78%. As a group, research analysts anticipate that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 12th. Shareholders of record on Monday, November 17th will be issued a $0.45 dividend. This represents a $1.80 annualized dividend and a yield of 2.6%. The ex-dividend date of this dividend is Monday, November 17th. U.S. Physical Therapy’s dividend payout ratio (DPR) is currently 75.63%.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.